These tests are typically offered to people at average or increased risk based on factors like age, family history, or lifestyle.
Cancer screening and early detection play a critical role in reducing the burden of cancer worldwide. The earlier cancer is detected, the more likely it can be treated successfully—often with less aggressive therapies and better outcomes. In many cases, early detection can prevent cancer from progressing to a life-threatening stage or even identify precancerous changes that can be treated before cancer develops.
Screening involves testing healthy or asymptomatic individuals to identify signs of cancer before symptoms appear. These tests are typically offered to people at average or increased risk based on factors like age, family history, or lifestyle. Common cancer screening tests include mammograms (for breast cancer), Pap smears and HPV testing (for cervical cancer), colonoscopies (for colorectal cancer), and low-dose CT scans (for lung cancer in high-risk individuals).
Early detection includes not just organized screening programs, but also patient and physician awareness of warning signs and symptoms, timely diagnosis, and follow-up care. It involves vigilance from both healthcare professionals and individuals, encouraging prompt attention to unexplained changes in health.
Breast Cancer – Mammography (usually starting at age 40–50, depending on guidelines).
Cervical Cancer – Pap smear and HPV testing (starting at age 21 or as recommended).
Colorectal Cancer – Colonoscopy, sigmoidoscopy, or stool tests (starting at age 45).
Lung Cancer – Low-dose CT scan for high-risk smokers aged 50–80.
Prostate Cancer – PSA blood test (based on individual risk and age).
Skin Cancer – Visual skin exams (self-exams or dermatologist screenings).
Oral Cancer – Visual and tactile examination, especially in tobacco users.
